Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Department of Pharmacology, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, BG Nagara, Mandya 571448, India.
Molecules. 2022 Jul 6;27(14):4336. doi: 10.3390/molecules27144336.
Diabetes mellitus (DM) and its complications are a severe public health concern due to the high incidence, morbidity, and mortality rates. The present study aims to synthesize and characterize silver nanoparticles (AgNPs) using the aqueous leaf extract of (PGE) for investigating its antidiabetic activity. silver nanoparticles (PGAg NPs) were prepared and characterized by various parameters. The in vivo study was conducted using PGE and PGAg NPs in Streptozotocin (STZ)-induced diabetic rats to assess their antidiabetic properties. STZ of 55 mg/kg was injected to induce diabetes. The PGE, PGAg NPs at a dose of 200 and 400 mg/kg and standard drug Metformin (100 mg/kg) were administered daily to diabetic rats for 21 days through the oral route. Blood glucose level, body weight changes, lipid profiles, and histopathology of the rats' liver and pancreas were examined. In the diabetic rats, PGE and PGAg NPs produced a drastic decrease in the blood glucose level, preventing subsequent weight loss and ameliorating lipid profile parameters. The histopathological findings revealed the improvements in pancreas and liver cells due to the repercussion of PGE and PGAg NPs. A compelling effect was observed in all doses of PGE and PGAg NPs; however, PGAg NPs exhibited a more promising result. Thus, from the results, it is concluded that the synthesized PGAg NPs has potent antidiabetic activity due to its enhanced surface area and smaller particle size of nanoparticles.
糖尿病(DM)及其并发症是一个严重的公共卫生问题,因为其发病率、发病率和死亡率都很高。本研究旨在使用(PGE)的水提叶片来合成和表征银纳米粒子(AgNPs),并研究其抗糖尿病活性。通过各种参数制备和表征了银纳米粒子(PGAg NPs)。使用 PGE 和 PGAg NPs 在链脲佐菌素(STZ)诱导的糖尿病大鼠中进行了体内研究,以评估它们的抗糖尿病特性。注射 55mg/kg 的 STZ 诱导糖尿病。PGE、PGAg NPs 剂量为 200 和 400mg/kg 和标准药物二甲双胍(100mg/kg)通过口服途径每天给予糖尿病大鼠,共 21 天。检查大鼠的血糖水平、体重变化、血脂谱以及肝脏和胰腺的组织病理学。在糖尿病大鼠中,PGE 和 PGAg NPs 使血糖水平急剧下降,防止随后的体重减轻并改善血脂谱参数。组织病理学发现由于 PGE 和 PGAg NPs 的影响,胰腺和肝细胞得到了改善。所有剂量的 PGE 和 PGAg NPs 都观察到了强烈的效果;然而,PGAg NPs 表现出更有希望的结果。因此,从结果可以得出结论,合成的 PGAg NPs 具有很强的抗糖尿病活性,这是由于其增强的表面积和更小的纳米粒子粒径。